Women and
heart disease: questions remain
Historically women
have not been the focus of many studies about heart disease. This
is gradually changing, and were hopeful many of the questions
we have about the similarities and differences between men and women and heart disease will be answered.
"
women do benefit from cholesterol-lowering medications as much, if not more so, than men."
We do know, however, based on studying some of the subpopulations
of women involved in studies, women do benefit from cholesterol-lowering
medications as much, if not more so, than men. The question remains
why, as this latest study shows, are they not being treated as aggressively
as men. And given the overwhelming evidence cholesterol-lowering medications
reduce the incidence of heart attacks and mortality, why were the
percentages of people taking the medications so low in this studymen
and women.
The study underscores the importance of the questions, but we dont
yet have the answers. In addition to intervention with medications,
there is also evidence primary care physicians are not stressing the
importance of a low-fat diet and exercise, smoking cessation and blood
pressure management with their female patients. These are all well
documented lifestyle modifications that can minimize a womans
risk for heart disease, and physicians need to spend time making sure
their patients understand them.
Time and care coordination important for cardiac education
Part of the problem may be lack of time. Many patient visits focus
on taking care of immediate health problems and performing physical
exams and routine screening tests. Taking time to counsel and educate
patients about diet, exercise and risk factors sometimes loses out
to the realities of time pressure.
"
women too often regard heart disease as something that
affects men more than women, and they may feel a false sense of security
that keeps them from being proactive in this regard."
Another factor may be a lack of care coordination. Women often regard
their ob-gyns as their primary care physicians, and these specialists
may not include cholesterol screening and risk factor analysis as
part of their annual visit. Also, women too often regard heart disease
as something that affects men more than women, and they may feel a
false sense of security that keeps them from being proactive in this
regard. The fact is heart disease is the number one killer of both
men and women.
Take charge of your health
There are several things women can do to take responsibility for their
health. I recommend people have a cholesterol screening when theyre
in their 20s with updates every five years. They should know their
scores for total cholesterol, high density and low density lipids
and triglycerides. Not only should women be screened, they should
understand what the numbers mean and what role HDL "good"
and LDL "bad" cholesterol play in whether arteries are healthy
or diseased.
If a womans cholesterol profile places her at risk, she needs
to talk with her doctor about lifestyle modifications; specific cholesterol
targets should be set and times should be established to measure if
these changes are making a difference. If lifestyle modifications
dont sufficiently reduce risk, women need to discuss medication
options with their physicians.
Women who are placed on cholesterol-lowering medications need to understand
how it is supposed to affect the different components of their cholesterol
profile, what side effects they may experience and how the medication
may interact with others they may take.
Women who prepare for medical visits with specific questions related
to heart disease are more likely to get attention. I give women a
checklist of five questions to ask their doctors to help ensure they
have the information they need (see box at left).
Those at special risk
Some women with a very strong family history of heart disease and
women with diabetes are at high risk for heart disease. It is particularly
important they understand that risk and form a relationship with physicians
who will work with them to develop an action plan and follow their
progress closely.
The good news is that we have several effective medications to reduce
cholesterol levels, and pharmaceutical companies have several new
ones in their pipelines, which are likely to offer physicians and
patients more and better choices.
Dr. Caulin-Glaser
is a cardiologist at Yale-New Haven Hospital, an assistant professor
of cardiology at the Yale School of Medicine and medical director
of the Temple Cardiac Rehabilitation Center.